{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:27:59Z","timestamp":1784734079815,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China grant","doi-asserted-by":"crossref","award":["81402945"],"award-info":[{"award-number":["81402945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Key Medical Discipline (Specialty) Construction Project grant","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"DOI":"10.13039\/501100019062","name":"Tianjin Research Innovation Project for Postgraduate Students","doi-asserted-by":"publisher","award":["2021YJSB265"],"award-info":[{"award-number":["2021YJSB265"]}],"id":[{"id":"10.13039\/501100019062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1007\/s11418-023-01757-z","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T19:02:26Z","timestamp":1702321346000},"page":"285-295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Upregulation of tumor suppressor PIAS3 by Honokiol promotes tumor cell apoptosis via selective inhibition of STAT3 tyrosine 705 phosphorylation"],"prefix":"10.1007","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-9421-0665","authenticated-orcid":false,"given":"Yue","family":"Fei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihua","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"issue":"15","key":"1757_CR1","doi-asserted-by":"publisher","first-page":"7511","DOI":"10.1080\/07391102.2022.2120541","volume":"41","author":"F Khatoon","year":"2023","unstructured":"Khatoon F et al (2023) Pharmacological features, health benefits and clinical implications of honokiol. J Biomol Struct Dyn 41(15):7511\u20137533","journal-title":"J Biomol Struct Dyn"},{"issue":"2","key":"1757_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086369","volume":"9","author":"X Wang","year":"2014","unstructured":"Wang X et al (2014) Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS ONE 9(2):e86369","journal-title":"PLoS ONE"},{"issue":"5","key":"1757_CR3","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1182\/blood-2005-01-0346","volume":"106","author":"K Ishitsuka","year":"2005","unstructured":"Ishitsuka K et al (2005) Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106(5):1794\u20131800","journal-title":"Blood"},{"issue":"4","key":"1757_CR4","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-07-1926","volume":"14","author":"ER Hahm","year":"2008","unstructured":"Hahm ER et al (2008) Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 14(4):1248\u20131257","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1757_CR5","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1002\/cncr.22551","volume":"109","author":"K Shigemura","year":"2007","unstructured":"Shigemura K et al (2007) Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109(7):1279\u20131289","journal-title":"Cancer"},{"issue":"1\u20133","key":"1757_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2008.06.026","volume":"591","author":"H Liu","year":"2008","unstructured":"Liu H et al (2008) Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer. Eur J Pharmacol 591(1\u20133):43\u201351","journal-title":"Eur J Pharmacol"},{"issue":"22","key":"1757_CR7","doi-asserted-by":"publisher","first-page":"18585","DOI":"10.1021\/acsami.8b04854","volume":"10","author":"Y Zou","year":"2018","unstructured":"Zou Y et al (2018) Synergistically enhanced antimetastasis effects by honokiol-loaded pH-sensitive polymer-doxorubicin conjugate micelles. ACS Appl Mater Interfaces 10(22):18585\u201318600","journal-title":"ACS Appl Mater Interfaces"},{"key":"1757_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.phymed.2018.06.012","volume":"49","author":"CC Chio","year":"2018","unstructured":"Chio CC et al (2018) Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway. Phytomedicine 49:41\u201351","journal-title":"Phytomedicine"},{"key":"1757_CR9","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.actbio.2017.08.027","volume":"62","author":"Z Wang","year":"2017","unstructured":"Wang Z et al (2017) Concurrently suppressing multidrug resistance and metastasis of breast cancer by co-delivery of paclitaxel and honokiol with pH-sensitive polymeric micelles. Acta Biomater 62:144\u2013156","journal-title":"Acta Biomater"},{"issue":"4","key":"1757_CR10","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1158\/1078-0432.CCR-17-0345","volume":"24","author":"X Wang","year":"2018","unstructured":"Wang X et al (2018) Honokiol radiosensitizes squamous cell carcinoma of the head and neck by downregulation of survivin. Clin Cancer Res 24(4):858\u2013869","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1757_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3858\/emm.2008.40.6.617","volume":"40","author":"J Hu","year":"2008","unstructured":"Hu J et al (2008) Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity. Exp Mol Med 40(6):617\u2013628","journal-title":"Exp Mol Med"},{"key":"1757_CR12","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.phrs.2019.04.004","volume":"144","author":"K Banik","year":"2019","unstructured":"Banik K et al (2019) Honokiol for cancer therapeutics: a traditional medicine that can modulate multiple oncogenic targets. Pharmacol Res 144:192\u2013209","journal-title":"Pharmacol Res"},{"key":"1757_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41420-020-00315-w","volume":"6","author":"N Muniraj","year":"2020","unstructured":"Muniraj N et al (2020) Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discov 6:81","journal-title":"Cell Death Discov"},{"issue":"4","key":"1757_CR14","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1158\/1535-7163.MCT-11-0999","volume":"11","author":"S Ponnurangam","year":"2012","unstructured":"Ponnurangam S et al (2012) Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cells. Mol Cancer Ther 11(4):963\u2013972","journal-title":"Mol Cancer Ther"},{"issue":"9","key":"1757_CR15","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1158\/1078-0432.CCR-10-0333","volume":"16","author":"RJ Leeman-Neill","year":"2010","unstructured":"Leeman-Neill RJ et al (2010) Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 16(9):2571\u20132579","journal-title":"Clin Cancer Res"},{"issue":"3\u20134","key":"1757_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10495-020-01655-9","volume":"26","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Honokiol induces paraptosis-like cell death of acute promyelocytic leukemia via mTOR & MAPK signaling pathways activation. Apoptosis 26(3\u20134):195\u2013208","journal-title":"Apoptosis"},{"issue":"1","key":"1757_CR17","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.canlet.2015.08.030","volume":"370","author":"PS Yeh","year":"2016","unstructured":"Yeh PS et al (2016) Honokiol induces autophagy of neuroblastoma cells through activating the PI3K\/Akt\/mTOR and endoplasmic reticular stress\/ERK1\/2 signaling pathways and suppressing cell migration. Cancer Lett 370(1):66\u201377","journal-title":"Cancer Lett"},{"issue":"7","key":"1757_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2015.37","volume":"47","author":"L Qiu","year":"2015","unstructured":"Qiu L et al (2015) Honokiol ameliorates endothelial dysfunction through suppression of PTX3 expression, a key mediator of IKK\/IkappaB\/NF-kappaB, in atherosclerotic cell model. Exp Mol Med 47(7):e171","journal-title":"Exp Mol Med"},{"issue":"2","key":"1757_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1182\/blood-2004-11-4273","volume":"106","author":"TE Battle","year":"2005","unstructured":"Battle TE, Arbiser J, Frank DA (2005) The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106(2):690\u2013697","journal-title":"Blood"},{"key":"1757_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12885-016-2265-6","volume":"16","author":"JS Huang","year":"2016","unstructured":"Huang JS et al (2016) Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK\/STAT signaling pathway suppression and apoptosis induction. BMC Cancer 16:245","journal-title":"BMC Cancer"},{"issue":"21","key":"1757_CR21","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL et al (2022) The JAK-STAT pathway at 30: much learned, much more to do. Cell 185(21):3857\u20133876","journal-title":"Cell"},{"issue":"1","key":"1757_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X et al (2021) The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther 6(1):402","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1757_CR23","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMra1202117","volume":"368","author":"JJ O'Shea","year":"2013","unstructured":"O\u2019Shea JJ, Holland SM, Staudt LM (2013) JAKs and STATs in immunity, immunodeficiency, and cancer. N Engl J Med 368(2):161\u2013170","journal-title":"N Engl J Med"},{"key":"1757_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-110416-120628","volume":"35","author":"TA Waldmann","year":"2017","unstructured":"Waldmann TA, Chen J (2017) Disorders of the JAK\/STAT pathway in T Cell lymphoma pathogenesis: implications for immunotherapy. Annu Rev Immunol 35:533\u2013550","journal-title":"Annu Rev Immunol"},{"issue":"41","key":"1757_CR25","doi-asserted-by":"publisher","first-page":"5709","DOI":"10.1038\/onc.2017.164","volume":"36","author":"S Sengupta","year":"2017","unstructured":"Sengupta S et al (2017) Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic stat3. Oncogene 36(41):5709\u20135721","journal-title":"Oncogene"},{"issue":"5","key":"1757_CR26","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/jcp.22954","volume":"227","author":"P Rajendran","year":"2012","unstructured":"Rajendran P et al (2012) Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1. J Cell Physiol 227(5):2184\u20132195","journal-title":"J Cell Physiol"},{"issue":"5","key":"1757_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.molcel.2014.01.020","volume":"53","author":"Y Wang","year":"2014","unstructured":"Wang Y et al (2014) GdX\/UBL4A specifically stabilizes the TC45\/STAT3 association and promotes dephosphorylation of STAT3 to repress tumorigenesis. Mol Cell 53(5):752\u2013765","journal-title":"Mol Cell"},{"issue":"5344","key":"1757_CR28","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1126\/science.278.5344.1803","volume":"278","author":"CD Chung","year":"1997","unstructured":"Chung CD et al (1997) Specific inhibition of stat3 signal transduction by PIAS3. Science 278(5344):1803\u20131805","journal-title":"Science"},{"issue":"8","key":"1757_CR29","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1182\/blood-2006-04-017434","volume":"108","author":"Y Han","year":"2006","unstructured":"Han Y et al (2006) Loss of SHP1 enhances JAK3\/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma. Blood 108(8):2796\u20132803","journal-title":"Blood"},{"key":"1757_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.semcancer.2020.03.016","volume":"80","author":"CD Mohan","year":"2022","unstructured":"Mohan CD et al (2022) Targeting STAT3 signaling pathway in cancer by agents derived from mother nature. Semin Cancer Biol 80:157\u2013182","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"1757_CR31","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/nrm909","volume":"3","author":"DE Levy","year":"2002","unstructured":"Levy DE, Darnell JE Jr (2002) Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3(9):651\u2013662","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1757_CR32","first-page":"1727","volume":"118","author":"M Ernst","year":"2008","unstructured":"Ernst M et al (2008) STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118(5):1727\u20131738","journal-title":"J Clin Invest"},{"issue":"11","key":"1757_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798\u2013809","journal-title":"Nat Rev Cancer"},{"key":"1757_CR34","doi-asserted-by":"publisher","first-page":"6656","DOI":"10.1038\/ncomms7656","volume":"6","author":"VB Pillai","year":"2015","unstructured":"Pillai VB et al (2015) Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial sirt3. Nat Commun 6:6656","journal-title":"Nat Commun"},{"issue":"3","key":"1757_CR35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molonc.2014.01.004","volume":"8","author":"DB Avtanski","year":"2014","unstructured":"Avtanski DB et al (2014) Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3\/Zeb1\/E-cadherin axis. Mol Oncol 8(3):565\u2013580","journal-title":"Mol Oncol"},{"issue":"1","key":"1757_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cancers11010022","volume":"11","author":"Y Fan","year":"2018","unstructured":"Fan Y et al (2018) Honokiol eliminates glioma\/glioblastoma stem cell-like cells via JAK-STAT3 signaling and inhibits tumor progression by targeting epidermal growth factor receptor. Cancers (Basel) 11(1):22","journal-title":"Cancers (Basel)"},{"key":"1757_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114913","volume":"391","author":"G Pulivendala","year":"2020","unstructured":"Pulivendala G, Bale S, Godugu C (2020) Honokiol: a polyphenol neolignan ameliorates pulmonary fibrosis by inhibiting TGF-beta\/Smad signaling, matrix proteins and IL-6\/CD44\/STAT3 axis both in vitro and in vivo. Toxicol Appl Pharmacol 391:114913","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-023-01757-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01757-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T15:27:59Z","timestamp":1709134079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-023-01757-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["1757"],"URL":"https:\/\/doi.org\/10.1007\/s11418-023-01757-z","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}